Catheter ablation of ventricular tachycardia in patients with structural heart disease

John M. Miller, Gregory T. Altemose, J. Vijay Jayachandran, Fred Morady

Research output: Contribution to journalReview article

1 Scopus citations


Radiofrequency catheter ablation has revolutionized therapy of most forms of supraventricular tachycardia and ventricular tachycardia in the absence of structural heart disease by providing arrhythmia cure in almost 90% of patients. However, this treatment has not been nearly as successful in patients with ventricular tachycardia in the setting of structural heart disease, because of a number of factors. Some of these limitations are technical (imprecise mapping tools, multiple regions requiring ablation) although others are patient-related (hemodynamic instability during arrhythmia, progression of disease process). Because of these and other factors, the majority of patients in this group are treated with implantable defibrillators. Ablative therapy has an adjunctive role in their management, mainly to decrease the frequency of device therapy (particularly shocks). This review will discuss mapping and ablation techniques as well as patient selection and evaluation for this procedure.

Original languageEnglish (US)
Pages (from-to)302-311
Number of pages10
JournalCardiology in Review
Issue number6
StatePublished - Jan 1 2001


  • Cardiomyopathy
  • Catheter ablation
  • Ventricular tachycardia

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Catheter ablation of ventricular tachycardia in patients with structural heart disease'. Together they form a unique fingerprint.

  • Cite this